Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:12 PM
Ignite Modification Date:
2025-12-26 @ 11:12 PM
NCT ID:
NCT00044512
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed primary hepatocellular carcinoma (HCC)
* Inoperable disease (T2-T4, any N, M0 or M1) or refused surgery
* Measurable disease
* At least 1 bidimensionally measurable lesion of at least 2 cm by computed tomography (CT) scan or magnetic resonance imaging (MRI)
* Presence of at least 1 of the following:
* Alpha-fetoprotein greater than the upper limit of normal (ULN)
* Hepatitis C antibody positive
* Hepatitis B surface antigen positive
* Child's Pugh class A or B
* Candidate for systemic therapy
Exclusion Criteria:
* Fibrolamellar disease mixed histology
* Metastatic brain or meningeal tumors
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00044512
Study Brief:
Protocol Section:
NCT00044512